Literature DB >> 183463

Selective removal of hypersecreting pituitary adenomas? An analysis of endocrine function, operative and microscopical findings in 101 cases.

D Lüdecke, R Kautzky, W Saeger, D Schrader.   

Abstract

The aim of this study of 101 pre- and postoperatively controlled hypersecreting pituitary adenomas (80 acromegalies, 15 Cushing's diseases, 6 Nelson's syndromes) was to establish in what cases a selective adenoma extirpation by the transnasal route is possible and advisable. In primary operations on acromegalics with small and medium size tumours 92% were postoperatively GH normal. Eighty five per cent of these had intact pituitary function. The results with larger tumours were worse (72%). During a control period of 1.5-5.5 years a renewed elevation of GH levels was observed in three cases, all in the first year, but never after clearly selective adenomectomy. These results, and the anterior lobe biopsies, which showed no GH cell hyperplasia, favour selective adenoma extirpation. In contrast to acromegaly, nodular ACTH cell hyperplasia in the anterior lobe was found in most cases of Cushing's disease, and therefore complete hypophysectomy was performed. The cortisol levels became either normal or, in most cases, lower than normal. A selective operation was performed on 6 Nelson tumors. The ACTH values became normal in about 50% of the patients but there was a tendency towards recurrence. Our experiences with Cushing's disease and Nelson's syndrome lead us to recommend total hypophysectomy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 183463     DOI: 10.1007/bf01405930

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  25 in total

1.  ACTH-producing pituitary tumors following adrenalectomy for Cushing's syndrome.

Authors:  D H NELSON; J W MEAKIN; G W THORN
Journal:  Ann Intern Med       Date:  1960-03       Impact factor: 25.391

2.  [Ultrastructure of hyperplastic and adenomatous corticotrophic cells in Cushing's syndrome of hypothalamic-hypophyseal origin (author's transl)].

Authors:  W Saeger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

3.  ACTH determinations before and after selective removal of pituitary adenomas in Nelson's syndrome.

Authors:  A Espinoza; H Nowakowski; R Kautzky; D Lüdecke
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1973

4.  [Current indications of stereotaxic interstitial irradiation in acromegaly. Ophthalmologic and neuroendocrinologic correlations in relation to prolonged time].

Authors:  J Talairach; C Schaub; G Szikla; D Recoules; O Boujard; M T Bleut-Pajot; J Nassiet; C Lornet
Journal:  Neurochirurgie       Date:  1974 Jul-Aug       Impact factor: 1.553

5.  Electron microscopy and histochemical correlation of human anterior pituitary cells.

Authors:  C Paiz; G R Hennigar
Journal:  Am J Pathol       Date:  1970-04       Impact factor: 4.307

6.  Specific demonstration of the human hypophyseal cells which produce adrenocorticotropic hormone.

Authors:  R F Phifer; S S Spicer; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1970-10       Impact factor: 5.958

7.  Transphenoidal microsurgery for acromegaly. Successful treatment with preservation of pituitary function.

Authors:  D P Becker; R Atkinson; R Sakalas; J K Vries; H F Young; F S Vines; J Martinez
Journal:  Confin Neurol       Date:  1974

8.  Radiation therapy for primary pituitary tumors associated with Cushing's syndrome.

Authors:  S H Levitt; C A Prather; C R Bogardus
Journal:  Clin Radiol       Date:  1970-01       Impact factor: 2.350

9.  Cushing's syndrome and pituitary tumors. Pathophysiology and ocular manifestations of ACTH-secreting pituitary adenomas.

Authors:  R L Rovit; T D Duane
Journal:  Am J Med       Date:  1969-03       Impact factor: 4.965

10.  Transsphenoidal hypophysectomy.

Authors:  J Hardy
Journal:  J Neurosurg       Date:  1971-04       Impact factor: 5.115

View more
  22 in total

1.  Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.

Authors:  D Giannella-Neto; B L Wajchenberg; B B Mendonça; S F Almeida; M Macchione; E M Spencer
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

2.  Endocrinological differentiation of primary hypothalamic and pituitary disease.

Authors:  E E Müller
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

3.  Diagnosis, treatment and postoperative results of Cushing's disease.

Authors:  N Kageyama; A Kuwayama; T Takahashi; M Negoro; K Ichihara
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

Review 4.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

5.  Recent developments in the treatment of acromegaly.

Authors:  D K Lüdecke
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

6.  [Diagnostic procedures in diencephalo-hypophyseal insufficiency (author's transl)].

Authors:  H G Solbach; W Wiegelmann; H K Kley; K H Rudorff; H L Krüskemper
Journal:  Klin Wochenschr       Date:  1979-05-16

7.  Evaluation of surgically treated Nelson's syndrome.

Authors:  D K Lüdecke; H J Breustedt; J Brämswig; J Köbberling; W Saeger
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

8.  [Comparative studies of growth hormone secretion in acromegaly after isolated and combined application of insulin hypoglycemia, LH-RH- and TRH tests (author's transl)].

Authors:  K R Schneider; G Müller; W Wiegelmann; H G Solbach; H L Krüskemper
Journal:  Klin Wochenschr       Date:  1978-05-01

9.  Results of surgical management of 319 pituitary adenomas.

Authors:  B Guidetti; B Fraioli; G P Cantore
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

10.  Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.

Authors:  M L Hartman; S M Pincus; M L Johnson; D H Matthews; L M Faunt; M L Vance; M O Thorner; J D Veldhuis
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.